This is important, and also current! Not holding my breath but it's a step forward
Viking Therapeutics' VK0214 Receives FDA Orphan... - AMN EASIER
Viking Therapeutics' VK0214 Receives FDA Orphan Drug Designation for the Treatment of X-Linked Adrenoleukodystrophy
Written by
wilburlois15
To view profiles and participate in discussions please or .
2 Replies
•
Sounds like a good start. A long time since there's been anything offering some hope of a reduction of our symptoms.
I contacted Viking and gave the number to my neurologist who I found out also called them. The big surprise was they actually called me back to confirm she was my neurologist. That's something. Hopefully this goes somewhere.
Not what you're looking for?
You may also like...
Viking Therapeutics drug VK0214-102
a trial for the Viking Therapeutics drug VK0214-102, which is a potential treatment for AMN....